Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder-Reference-Cited by-同舟云学术

Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder

Published:2015-04 Issue:4 Volume:33 Page:165.e15-165.e24
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Dohn Line Hammer,Illemann Martin,Høyer-Hansen Gunilla,Christensen Ib J.,Hostmark Jens,Litlekalsoy Jorunn,von der Maase Hans,Pappot Helle,Laerum Ole D.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference32 articles.

1. International Agency for Research on Cancer, Lyon, France. http://globocan.iarc.fr; 2013 [accessed 18.03.14].

2. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines;Witjes;Eur Urol,2014

3. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients;Hautmann;Eur Urol,2012

4. ICUD-EAU international consultation on bladder cancer 2012: screening, diagnosis, and molecular markers;Kamat;Eur Urol,2013

5. Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder;Xylinas;Urol Oncol,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and evaluation of [64Cu]Cu-DOTATATE for clinical applications;IRAN J NUCL MED;2023

2. The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities;Cancers;2021-10-27

3. Effects of Lymphovascular Invasion on Overall and Cancer-specific Survival after Radical Cystectomy in Patients with Bladder Cancer;The Bulletin of Urooncology;2021-08-27

4. Targeting the Urokinase-Type Plasminogen Activator Receptor (uPAR) in Human Diseases With a View to Non-invasive Imaging and Therapeutic Intervention;Frontiers in Cell and Developmental Biology;2021-08-20

5. Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder;Cancers;2021-05-14